TET1 and cancer: The fact that the aberrant elevated expression of this truncated TET1 isoform in cancers (breast, uterine, and ovarian) is associated with worse prognosis (Good et al., 2017) further indicates that the truncated isoform harbors distinct characteristics from those of the canonical full-length isoform, not only in the way it is recruited, but also in its function.